CHMP Favors EU Approval of Evrysdi as 1st Oral, At-home SMA Treatment & Discussing GI Issues

CHMP Favors EU Approval of Evrysdi as 1st Oral, At-home SMA Treatment & Discussing GI Issues

SMA News Today’s multimedia associate, Price Wooldridge, discusses the Committee for Medicinal Products for Human Use (CHMP) approval of Evrysdi as the first oral, at-home Spinal Muscular Atrophy (SMA) treatment. DeAnn Runge talks about her hesitancy to meet with a dietician to discuss GI issues she’s been dealing with. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Jaksot(444)

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
psykopodiaa-podcast
rss-pitaisko-erota
katilon-kahvitunti
puhu-muru
rss-uplevel-by-sonja-hannus
rss-rakas-mielenterveyteni
rss-narsisti
terapiassa
rss-ehjaksi
rss-duodecim-lehti
rss-vapaudu-voimaasi
selviytyjat-tarinoita-elamasta
rss-pt-paahtio
rss-eropodi
rss-mighty-finland-podcast
rss-kyykkya-ja-kuoharia